Complementation of two mutant p53: Implications for loss of heterozygosity in cancer

被引:8
|
作者
Demidenko, ZN
Fojo, T
Blagosklonny, MV
机构
[1] New York Med Coll, Brander Canc Res Inst, Valhalla, NY 10595 USA
[2] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源
FEBS LETTERS | 2005年 / 579卷 / 10期
关键词
cancer; p53; tumor suppressor;
D O I
10.1016/j.febslet.2005.03.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Remarkably, a cancer cell rarely possesses two mutant p53 proteins. Instead, mutation of one allele is usually associated with loss of the second p53 allele. Why do not two mutant p53 co-exist? We hypothesize that two different p53 may complement each other, when expressed at equal levels. By titrating trans-deficient and DNA-binding-deficient p53 in cells with mutant p53 and by co-transfecting distinct mutant p53 in p53-null cells, we demonstrated activation of p53-dependent transcription. We suggest that, due to complementation of two mutant p53, cancer cells need to delete the second p53 allele rather than mutate it. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.Ni. All rights reserved.
引用
收藏
页码:2231 / 2235
页数:5
相关论文
共 50 条
  • [1] Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53
    Amr Ghaleb
    Alisha Yallowitz
    Natalia Marchenko
    [J]. Communications Biology, 2
  • [2] Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53
    Ghaleb, Amr
    Yallowitz, Alisha
    Marchenko, Natalia
    [J]. COMMUNICATIONS BIOLOGY, 2019, 2 (01)
  • [3] Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells
    Ghaleb, Amr
    Padellan, Malik
    Marchenko, Natalia
    [J]. BREAST CANCER RESEARCH, 2020, 22 (01)
  • [4] p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
    Evguenia M Alexandrova
    Safia A Mirza
    Sulan Xu
    Ramona Schulz-Heddergott
    Natalia D Marchenko
    Ute M Moll
    [J]. Cell Death & Disease, 2017, 8 : e2661 - e2661
  • [5] p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
    Alexandrova, Evguenia M.
    Mirza, Safia A.
    Xu, Sulan
    Schulz-Heddergott, Ramona
    Marchenko, Natalia D.
    Moll, Ute M.
    [J]. CELL DEATH & DISEASE, 2017, 8 : e2661 - e2661
  • [6] Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells
    Amr Ghaleb
    Malik Padellan
    Natalia Marchenko
    [J]. Breast Cancer Research, 22
  • [7] Loss of heterozygosity and p53 expression in Pterygium
    Reisman, D
    McFadden, JW
    Lu, G
    [J]. CANCER LETTERS, 2004, 206 (01) : 77 - 83
  • [8] Loss of heterozygosity is related to p53 mutations and smoking in lung cancer
    Zienolddiny, S
    Ryberg, D
    Arab, MO
    Skaug, V
    Haugen, A
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (02) : 226 - 231
  • [9] Loss of heterozygosity is related to p53 mutations and smoking in lung cancer
    S Zienolddiny
    D Ryberg
    M O Arab
    V Skaug
    A Haugen
    [J]. British Journal of Cancer, 2001, 84 : 226 - 231
  • [10] LOSS OF HETEROZYGOSITY AND P53 GENE-MUTATIONS IN BREAST-CANCER
    DENG, G
    CHEN, LC
    SCHOTT, DR
    THOR, A
    BHARGAVA, V
    LJUNG, BM
    CHEW, K
    SMITH, HS
    [J]. CANCER RESEARCH, 1994, 54 (02) : 499 - 505